Gary Nelson
Adolescent Medicine · Orchard Park, NYNPI 1245209634
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,293 and has fallen 94.5% since, to $127 in 2022. Among adolescent medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$716
- Mallinckrodt Enterprises LLC$368
- AbbVie$191
- GSK$182
- Boehringer Ingelheim$154
- Pfizer$151
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,01498%
- Education$502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 6 | $716 |
| Mallinckrodt Enterprises LLC | 3 | $368 |
| AbbVie(2 entities) | 12 | $191 |
| GSK | 20 | $182 |
| Boehringer Ingelheim | 11 | $154 |
| Pfizer | 15 | $151 |
| Lilly USA, LLC | 12 | $146 |
| AstraZeneca | 9 | $145 |
| Amgen(2 entities) | 9 | $140 |
| Amarin Pharma, Inc. | 8 | $125 |
| Novo Nordisk | 8 | $122 |
| Sanofi-aventis U.S. LLC | 7 | $111 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $85 |
| Abbott | 4 | $72 |
| Kowa Pharmaceuticals America, Inc. | 4 | $62 |
| Grifols USA, LLC | 3 | $60 |
| Johnson & Johnson | 4 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Novartis | 3 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $25 |
| Mylan Specialty L.p. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Merck | 1 | $14 |
| Circassia Inc. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTHAR$1,083
How this compares
$3,065 in reported general payments places this provider in the 90th percentile of 257 adolescent medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $8,648 |
| Pantoprazole Sodium | 17 | $216 |
| Sertraline Hcl | 54 | $145 |
| Nortriptyline Hcl | 12 | $99 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $151 | $8,64815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 257 adolescent medicine providers in New York.
Other adolescent medicine in Orchard Park
- Joseph KitaOrchard Park$2K
- Melanie GoldNew York$61K
- Jonathan JasseyRoslyn$31K
- Michelle Collins-OgleBronx$13K
- Katherine GreenbergRochester$9K
- Juan EspinozaBrentwood$8K
- Anne MosconaNew York$7K
- Chelikani VarmaDepew$6K
- Maureen CooneyNyack$6K
- Michael RosenbaumNew York$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.